Esanex Obtains $10,746,664 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3ae79703-9688-4b55-9929-68ba7919a754&Preview=1 -
Date
12/12/2012 -
Company Name
Esanex -
Mailing Address
115 W. Washington St. Indianapolis, IN 46204 -
Company Description
Esanex, Inc. is a United States-based pharmaceutical company. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$10,746,664 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
